HomeREGULATORY
REGULATORY

Pfizer’s Breast Cancer Med Palbociclib Up for MHLW Panel Review on July 27
(Jul.14.2017)

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will review on July 27 whether to recommend approval for a batch of drugs including Pfizer’s breast cancer drug palbociclib, known as Ibrance overseas ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 28.

News Calendar